Yihuan Chen

Henan Province 450001, PR China
Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Diosmetin alleviates the immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma by dually inhibiting angiogenesis and promoting CD8+T cell cytotoxicity.

Diosmetin alleviates the immunosuppressive tumor microenvironment in esophageal squamous cell carcinoma by dually inhibiting angiogenesis and promoting CD8+T cell cytotoxicity.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 19, 2025

JAK3/STAT5A-dependent IL-8 regulation drives ESCC angiogenesis and is suppressed by dihydroartemisinin.

JAK3/STAT5A-dependent IL-8 regulation drives ESCC angiogenesis and is suppressed by dihydroartemisinin.

Journal: International immunopharmacology

Published: April 10, 2025

Selection and identification of DNA aptamer binding VDAC1 for tumor tissue imaging and targeted drug delivery.

Selection and identification of DNA aptamer binding VDAC1 for tumor tissue imaging and targeted drug delivery.

Journal: International journal of biological macromolecules

Published: December 25, 2024

Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine.

Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine.

Journal: Cancer letters

Published: July 17, 2023

PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway.

PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway.

Journal: Cellular signalling

Published: February 23, 2023

Joint analysis identified FAP as a prognostic and diagnostic biomarker correlated immune infiltration in gastric cancer.

Joint analysis identified FAP as a prognostic and diagnostic biomarker correlated immune infiltration in gastric cancer.

Journal: Pathology, research and practice

Published: November 03, 2022

Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin.

Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin.

Journal: Oncogene

Published: September 06, 2022

AGT serves as a potential biomarker and drives tumor progression in colorectal carcinoma.

AGT serves as a potential biomarker and drives tumor progression in colorectal carcinoma.

Journal: International immunopharmacology

Published: April 10, 2021

Dihydroartemisinin: A Potential Natural Anticancer Drug.

Dihydroartemisinin: A Potential Natural Anticancer Drug.

Journal: International journal of biological sciences

Published: July 06, 2020

Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer.

Identification of the collagen family as prognostic biomarkers and immune-associated targets in gastric cancer.

Journal: International immunopharmacology

Published: May 08, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026